Catheter ablation in patients with paroxysmal atrial fibrillation and absence of structural heart disease: A meta-analysis of randomized trials

Hindricks, 2021, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), Eur. Heart J., 42, 373, 10.1093/eurheartj/ehaa612 Magnocavallo, 2022, Catheter Ablation versus Medical Therapy of Atrial Fibrillation in Patients with Heart Failure: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials, JCM., 11, 5530, 10.3390/jcm11195530 Vetta, 2022, Non-conducted premature atrial complexes: A new independent predictor of atrial fibrillation in cryptogenic stroke, J. Electrocardiol., 74, 46, 10.1016/j.jelectrocard.2022.07.071 Lucà, 2023, Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation, Front. Cardiovasc. Med., 10, 1061618, 10.3389/fcvm.2023.1061618 Kirchhof, 2020, Early Rhythm-Control Therapy in Patients with Atrial Fibrillation, N. Engl. J. Med., 383, 1305, 10.1056/NEJMoa2019422 Andrade, 2023, Progression of Atrial Fibrillation after Cryoablation or Drug Therapy, N. Engl. J. Med., 388, 105, 10.1056/NEJMoa2212540 Ding, 2022, Cryoballoon catheter ablation or drug therapy to delay progression of atrial fibrillation: A single-center randomized trial, Front. Cardiovasc. Med., 9, 1003305, 10.3389/fcvm.2022.1003305 Kanagaratnam, 2023, Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial, EP Europace., 25, 863, 10.1093/europace/euac253 Kuck, 2021, Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST), EP Europace., 23, 362, 10.1093/europace/euaa298 Kuniss, 2021, Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation, EP Europace., 23, 1033, 10.1093/europace/euab029 Morillo, 2014, Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Randomized Trial, JAMA, 311, 692, 10.1001/jama.2014.467 Nielsen, 2003, A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome, J. Am. Coll. Cardiol., 42, 614, 10.1016/S0735-1097(03)00757-5 Pappone, 2011, Radiofrequency Catheter Ablation and Antiarrhythmic Drug Therapy: A Prospective, Randomized, 4-Year Follow-Up Trial: The APAF Study, Circ: Arrhythmia Electrophysiol., 4, 808 Wazni, 2021, Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation, N. Engl. J. Med., 384, 316, 10.1056/NEJMoa2029554 Wazni, 2005, Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial, JAMA, 293, 2634, 10.1001/jama.293.21.2634 Wilber, 2010, Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Controlled Trial, JAMA, 303, 333, 10.1001/jama.2009.2029 Sohara, 2016, HotBalloon Ablation of the Pulmonary Veins for Paroxysmal AF, J. Am. Coll. Cardiol., 68, 2747, 10.1016/j.jacc.2016.10.037 Cosedis Nielsen, 2012, Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation, N. Engl. J. Med., 367, 1587, 10.1056/NEJMoa1113566 M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ 2021 (2020) n71. Bordignon, 2022, The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management, EP Europace., 24, 1684, 10.1093/europace/euac131 Turagam, 2021, Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials, JAMACardiol., 6, 697 Kheiri, 2021, Ablation Versus Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation: A Meta-Analysis of Randomized Trials, Circ. Arrhythm. Electrophysiol., 14, e009692, 10.1161/CIRCEP.120.009692 Gunawardene, 2022, Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes, EP Europace., 24, 10.1093/europace/euab257 Walters, 2016, Progression of atrial remodeling in patients with high-burden atrial fibrillation: Implications for early ablative intervention, Heart Rhythm., 13, 331, 10.1016/j.hrthm.2015.10.028 Verma, 2015, Approaches to Catheter Ablation for Persistent Atrial Fibrillation, N. Engl. J. Med., 372, 1812, 10.1056/NEJMoa1408288 Kuck, 2016, Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation, N. Engl. J. Med., 374, 2235, 10.1056/NEJMoa1602014 Lee, 2023, S2405500X23000026 Parlavecchio, 2023, High power short duration versus low power long duration ablation in patients with atrial fibrillation: A meta-analysis of randomized trials, Pacing Clin. Electrophysiol., 10.1111/pace.14838 Reddy, 2023, Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation, N Engl J Med., 10.1056/NEJMoa2307291 Packer, 2019, Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial, JAMA, 321, 1261, 10.1001/jama.2019.0693 Rillig, 2022, Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden, Circulation, 146, 836, 10.1161/CIRCULATIONAHA.122.060274 Della Rocca, 2021, Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry, EP Europace., 23, 1939, 10.1093/europace/euab161